PTH and chronic kidney disease: Nevertheless, the associations between elevated PTH levels and morbidity and mortality [2] indicate a need for effective management of SHPT without delaying treatment until these elevations become severe and progressive in CKD stage G4–5 and at which point the benefits of using calcitriol/active vitamin D may be more balanced against the risks of hypercalcaemia [7].